Clinical Neuroscience Solutions, Inc.

Clinical research site in Memphis, Tennessee

Part of Clinical Neuroscience Solutions

As of July 2026, 6 paid clinical trials are recruiting at Clinical Neuroscience Solutions, Inc. in Memphis, Tennessee. Active studies at this site cover conditions such as Major Depressive Disorder, Attention-Deficit/Hyperactivity Disorder and Chronic Migraine. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Clinical Neuroscience Solutions, Inc. (6)

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

for Clostridioides Difficile Associated Disease

135 locations incl. Athens

Sponsor: Pfizer

Sex: All·Age: 65+·Accepts healthy volunteers

Code: NCT07282665·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

for Bipolar Disorder

28 locations incl. Tucson

Sponsor: Xenon Pharmaceuticals Inc.

Sex: All·Age: 18 - 74

Code: NCT07172516·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

for Episodic Migraine

68 locations incl. Birmingham

Sponsor: Ipsen

Sex: All·Age: 18 - 80

Code: NCT06625060·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

for Atopic Dermatitis

43 locations incl. Birmingham

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT05995964·Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

for Major Depressive Disorder

45 locations incl. Phoenix

Sponsor: Xenon Pharmaceuticals Inc.

Sex: All·Age: 18 - 74

Code: NCT06775379·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

for Attention-Deficit/Hyperactivity Disorder

47 locations incl. Saraland

Sponsor: Supernus Pharmaceuticals, Inc.

Sex: All·Age: 48 Months - 69 Months

Code: NCT04781140·Phase 4·Recruiting·Listed Mar 2021

Apply to this trial

More research sites in Memphis

St. Jude Children's Research Hospital (124 trials)
Baptist Memorial Hospital and Cancer Center-Memphis (53 trials)
Saint Jude Children's Research Hospital (31 trials)
Le Bonheur Children's Hospital (22 trials)
University of Tennessee Health Science Center (12 trials)
Baptist Cancer Center (12 trials)
Baptist Clinical Research Institute (8 trials)
Regional One Health (8 trials)
LeBonheur Children's Hospital (7 trials)
Southern College of Optometry (7 trials)

Explore more

Paid clinical trials in Memphis, TN · Tennessee clinical trials